Stockscreener 앱 받기
265.44
0.26%
0.69
시간 외 거래:
265.44
Cencora Inc 주식(COR)의 최신 뉴스
Cencora Announces Updated Fiscal Year 2026 Financial Outlook - marketscreener.com
Cencora stock (US15135B1017): transformation story after name change and solid earnings - AD HOC NEWS
Cencora stock (US15135B1017): Earnings miss and legal probe weigh on shares - AD HOC NEWS
Cencora, Inc. (COR) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora hits 52-week low after guidance cut - MSN
Cencora stock (US15135B1017): Q2 miss, legal probe and what matters now for investors - AD HOC NEWS
Cencora stock (US15135B1017): dividend track record and legal investigation in focus - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Is Investigating Cencora, Inc. (COR) And Encourages Investors to Connect - The National Law Review
Investors can join fraud probe against Cencora after Q2 miss and revenue drop claims. - Pluang
COR Investors Have Opportunity to Join Cencora, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
COR Investors Have Opportunity to Join Cencora, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire Inc.
Cencora (COR) Emerges as a Healthcare Leader with Robust Fundamentals and Strategic Re-Rating - Insider Monkey
Cencora stock (US15135B1017): revenue miss, guidance tweak and share price pressure in focus - AD HOC NEWS
Cencora Inc. stock underperforms Wednesday when compared to competitors - MSN
Will Cencora’s (COR) Revenue Miss and Probes Change Its Margin-Expansion Narrative? - simplywall.st
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? - MSN
Is It Time To Revisit Cencora (COR) After The Recent Share Price Slump? - simplywall.st
Rosen Law Firm Encourages Cencora, Inc. Investors to Inquire About Securities Class Action Investigation – COR - The Joplin Globe
Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch
Cencora stock (US15135B1017): pharma distributor reshapes portfolio after latest earnings - AD HOC NEWS
Wells Fargo Maintains Overweight Rating on Cencora (COR) - Insider Monkey
Bronstein, Gewirtz & Grossman, LLC Is Investigating Cencora, Inc. (COR) And Encourages Stockholders to Connect - The National Law Review
Cencora, Inc. Common Stock (NY: COR - FinancialContent
Cencora faces securities fraud probe after missing revenue targets and stock plunge. - Pluang
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc.COR - PR Newswire
Cencora, Inc.: - marketscreener.com
Cencora Inc. stock (US15135B1017): dividend date and legal probe in focus for investors - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
CAH Stock Down Nearly 9.4% YTD: Should You Buy, Hold or Sell? - TradingView
ETFs Investing in Cencora, Inc. Stocks - TradingView
Are Wall Street Analysts Bullish on Cencora Stock? - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Cencora, Inc. (COR) Investors to Inquire about Securities Investigation - The National Law Review
Cencora Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Cencora stock (US15135B1017): Q2 2026 earnings show 7% revenue growth - AD HOC NEWS
Cencora stock (US15135B1017): Q2 earnings miss, analyst downgrades weigh on shares - AD HOC NEWS
Why is Cencora stock trading lower on Wednesday? - MSN
Why Cencora (COR) is a Top Growth Stock for the Long-Term - Yahoo Finance
Cencora stock (US15135B1017): Drops 17% after Q2 earnings miss - AD HOC NEWS
Houston County receives state funding for industrial access work tied to Cencora expansion - WTVY
Securities Fraud Investigation Into Cencora, Inc. (COR) Announced - The National Law Review
TD Cowen reiterates Cencora stock Buy rating on generics thesis - Investing.com UK
TD Cowen reiterates Cencora stock Buy rating on generics thesis By Investing.com - Investing.com South Africa
Securities Fraud Investigation Into Cencora, Inc. (COR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - ChartMill
Research Alert: CFRA Maintains Buy Rating On Shares Of Cencora - Moomoo
Cencora (COR) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
FinancialContentCencora, Inc. (COR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - FinancialContent
Kepler Cheuvreux Suisse SA Has $9.77 Million Position in Cencora, Inc. $COR - MarketBeat
Cencora (NYSE:COR) Could Be A Buy For Its Upcoming Dividend - simplywall.st
Cencora, Inc. (COR) Stock Analysis: A 36.74% Potential Upside In The Healthcare Sector - DirectorsTalk Interviews
Cencora Inc. stock (US15135B1017): Healthcare distribution leader posts solid Q2 results - AD HOC NEWS
0.69%
5.63%
자본화:
|
볼륨(24시간):